3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Colorectal Neoplasms
8
Melanoma
6
Colonic Neoplasms
4
Rectal Neoplasms
3
Carcinoma, Non-Small-Cell Lung
3
Lung Neoplasms
2
Thyroid Neoplasms
1
Solid Tumors
1
Skin Neoplasms
1
Pancreatic Neoplasms
1
Neurofibromatosis 1
1
Neoplasms
1
Lymphatic Metastasis
1
Leukemia, Hairy Cell
1
Hereditary Sensory and Autonomic Neuropathies
1
Gastrointestinal Neoplasms
1
Disease Progression
1
Digestive System Neoplasms
1
Brain Neoplasms
1
Biliary Tract Neoplasms
1
Interventions
Temozolomide
40
Magnetic Resonance Spectroscopy
19
Radiotherapy
18
Specimen Handling
14
Radiation
12
Bevacizumab
11
Lomustine
9
pembrolizumab
6
fludarabine
5
Surgical Procedures, Operative
5
atezolizumab
4
Nivolumab
4
Ipilimumab
4
Cyclophosphamide
4
Carboplatin
4
Biopsy
4
cemiplimab
3
azeliragon
3
Immunoglobulin G
3
Disulfides
3
Aminolevulinic Acid
3
veliparib
2
trametinib
2
rocakinogene sifuplasmid
2
poly ICLC
2
olaparib
2
lutetium Lu 177 dotatate
2
durvalumab
2
dabrafenib
2
contrast agent BR1
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Glioblastoma
×
encorafenib
×
90 days
×
Clear all
No trials found.